Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!"

Author(s):  McElhiney Linda F

Issue:  Jan/Feb 2009 - Compounding for Pediatrics
View All Articles in Issue

Page(s):  20-25

Compounding for Manufacturer Backorders and Discontinuations:
Compounding for Manufacturer Backorders and Discontinuations:
Compounding for Manufacturer Backorders and Discontinuations:
Compounding for Manufacturer Backorders and Discontinuations:
Compounding for Manufacturer Backorders and Discontinuations:
Compounding for Manufacturer Backorders and Discontinuations:

Download in electronic PDF format for $75

Abstract:  Drug shortages due to manufacturer backorders and discontinuations are a concern and frustration for pharmacists, physicians, and patients. Keeping up-to-date on the latest shortages, utilizing good key references, and using compounding as an alternative source for the drugs can keep the patients on their current therapy that is optimum for them. This article discusses some of the factors that influence drug supplies, provides some of the resources to find information on backordered or discontinued drugs, and provides some formulations as alternatives to backordered or discontinued medications.

Related Keywords: manufacturer backorders, drug discontinuations, drug shortages, discontinued drugs, formulations, information sources, hydrochlorothiazide, midazolam, amphotericin B, vancomycin hydrochloride, dosage forms, edetate disodium, ophthalmic preparation

Related Categories: FORMULATIONS, DISCONTINUED FORMULATIONS, PROFESSIONAL ISSUES, INFORMATION RESOURCES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!"
McElhiney Linda F
Jan/Feb 2009
Pg. 20-25

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
Nov/Dec 2012
Pg. 456-460

PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 350-351

PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
Jul/Aug 2012
Pg. 268

The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients
Moore Renee
Sep/Oct 2012
Pg. 394-395

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
Mar/Apr 2022
Pg. 100-109

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again!
Allen Loyd V Jr
May/Jun 2023
Pg. 180

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
May/Jun 2013
Pg. 180

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

Book Reviews: Veterinary Drug Handbook: Client Information Edition
Reed-Kane Dana
May/Jun 2005
Pg. 173

Return to Top